...
首页> 外文期刊>Annals of allergy, asthma, and immunology >Factors that predict the clinical reactivity and tolerance in children with cow's milk allergy
【24h】

Factors that predict the clinical reactivity and tolerance in children with cow's milk allergy

机译:预测牛奶过敏儿童临床反应性和耐受性的因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Specific IgE (sIgE) may be used for the diagnosis of cow's milk allergy (CMA) and as a guide to perform food challenge tests in patients with CMA. The effect of genetic variants on the prognosis of food allergy is largely unknown. Objective: To examine the performance of sIgE analysis and the utility of the genetic variants of CD14, STAT6, IL13, IL10, SPINK5, and TSLP in predicting the clinical course in children with CMA. Methods: Serum sIgE levels of 94 children who underwent open food challenges and 54 children with anaphylaxis due to cow's milk (CM) were retrospectively analyzed between January 2002 and May 2009. The genetic polymorphisms were determined in 72 children. Results: A total of 148 children were followed up for a median of 3.5 years, and 42 of the 94 challenge results were positive. The probability curves with 95% decision points were 2.8 kU/L for younger than 1 year, 11.1 for younger than 2 years, 11.7 for younger than 4 years, and 13.7 for younger than 6 years. Sixty-six children outgrew CMA during follow-up. Children with initial an CM sIgE level less than 6 kU/L outgrew CMA earlier than children with an initial CM sIgE level of 6 kU/L or higher (P <.001). The age of tolerance development for CM was significantly higher in children with the GG genotype at rs324015 of the STAT6 gene compared with those with the AA+AG genotype (2 years [range, 1.5-3.9 years] vs 1.2 years [range, 1.0-2.2 years]) (P =.02). Conclusion: The decision points of sIgE obtained in different age groups may help to determine the likelihood of clinical reactivity more precisely. The results suggest that sIgE levels and STAT6 gene variants may be important determinants to predict longer persistence of CMA.
机译:背景:特异性IgE(sIgE)可用于诊断牛奶过敏(CMA),并可作为对CMA患者进行食物挑战测试的指南。遗传变异对食物过敏预后的影响很大程度上未知。目的:探讨sIgE分析的性能以及CD14,STAT6,IL13,IL10,SPINK5和TSLP的遗传变异在预测CMA儿童临床病程中的作用。方法:回顾性分析2002年1月至2009年5月间94例接受开放式食物挑战的儿童和54例因牛奶(CM)引起过敏反应的儿童的sIgE水平。确定了72例儿童的基因多态性。结果:总共对148名儿童进行了随访,中位时间为3.5岁,94项挑战结果中有42项为阳性。决策点为95%的概率曲线:1岁以下为2.8 kU / L,2岁以下为11.1,4岁以下为11.7,6岁以下为13.7。在随访期间,有66名儿童超过了CMA。初始CM sIgE水平低于6 kU / L的儿童比最初CM sIgE水平达到6 kU / L或更高的儿童的CMA生长早(P <.001)。在STAT6基因的rs324015处,具有GG基因型的儿童的CM耐受性发展年龄显着高于具有AA + AG基因型的儿童(2年[范围:1.5-3.9岁]与1.2岁[范围:1.0- 2.2年])(P = .02)。结论:不同年龄组获得的sIgE的决策点可能有助于更准确地确定临床反应的可能性。结果表明,sIgE水平和STAT6基因变异可能是预测CMA持续存在的重要决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号